Dapagliflozin for use in methods of treating heart failure with reduced ejection fraction
LT4021507TActive Publication Date: 2026-08-25ASTRAZENECA AB
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- LT4021507P0
- Authority / Receiving Office
- LT · LT
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2020-03-09
- Filing Date
- 2020-03-09
- Publication Date
- 2026-08-25
- Estimated Expiration
- 2040-03-09
Need to check novelty before this filing date? Find Prior Art
No text content released.